A buyer-underwriting-focused guide to supplement company valuation, including normalized EBITDA, SDE, revenue quality, channel mix, brand strength, manufacturing model, diligence risk, valuation methods, seller proceeds, and the steps founders can take to improve sale outcomes.
A buyer-underwriting-first guide to nutraceutical M&A, including why supplements, vitamins, and nutrition brands are attracting buyers, how acquirers frame valuation, where diligence risk changes deal terms, and what founders should fix before going to market.
A buyer-underwriting-focused guide to supplement company valuation multiples, including EBITDA and revenue multiple ranges, how buyers interpret benchmarks, why channel mix and compliance risk change pricing, and how the same revenue or EBITDA can produce very different seller outcomes.
A founder-focused guide to selling a supplement company, including how to prepare before market, build a defensible valuation case, target the right buyers, manage diligence, compare LOIs, protect seller proceeds, and avoid the issues that cause supplement deals to lose value.
A buyer-underwriting-focused guide to who buys supplement companies, including strategic acquirers, private equity platforms, add-on buyers, family offices, distributors, contract manufacturers, adjacent wellness buyers, buyer-fit logic, diligence priorities, offer structure, and what founders should prepare before market.